Page 16 - Use Listing News Today

WHO Director-General Tedros Adhanom Ghebreyesus said on Thursday that COVID-19 vaccine manufacturers should only send doses to countries where few are inoculated.

The EUL risk-benefit assessment is essential for granting emergency use authorisation(EUA) to the Covid-19 vaccine by the global health body. Bharat Biotech has been submitting data to WHO on a rolling basis. 

The clearance for using Covaxin on children will take much less time, World Health Organization (WHO) chief scientist Dr Soumya Swaminathan told NDTV after the Bharat Biotech-manufactured vaccine's Emergency Use Listing.

World Health Organisation South-East Asia Regional Director Dr Poonam Khetrapal Singh has congratulated India on the Emergency Use Listing of Bharat Biotech

Covaxin, by no means, took the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, Chief Scientist Dr Soumya Swaminathan said today

Chinese President Xi Jinping o...

Xi Jinping "proposed a six-point Global Vaccine Cooperation Action Initiative"

The WHO-IHR Emergency Committee has asked not to use vaccine certificates as the only criterion for international travel as such policies are affecting global education and business.

The WHO technical advisory group will meet on November 3 for a final risk-benefit assessment.

Bharat Biotech has been submitting data to WHO on a rolling basis and submitted additional information at the UN health bodys request on September 27.